Navigation Links
Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
Date:6/5/2008

NEW YORK, June 5 /PRNewswire/ -- Cline Davis & Mann (CDM), a leading healthcare communication services company, announced the launch of its newest division, Platform Advisors(TM). Platform Advisors, based in New York, provides fully integrated strategic and scientific consulting services for pharmaceutical, biotechnology, and medical device companies.

Unlike traditional consulting firms, Platform Advisors combines the expertise of seasoned healthcare professionals and commercial strategists. The integrated approach provides a single source for strategic and scientific needs at every stage of a product's lifecycle. Platform Advisors has more than 40 medical professionals partnered with seasoned strategists who focus only on commercialization of healthcare products.

Platform Advisors was created in response to a growing customer need for early commercialization strategies. Platform Advisors, led by Lori Klein, Managing Partner, provides services that include portfolio strategy, licensing, valuations, forecasting, early commercialization, and clinical strategy. "With our integrated approach, we offer expertise in both 'The science of business and the business of science' -- at every stage of a product's lifecycle."

"We are really pleased to offer these services for our clients. Now we can partner with companies from discovery to launch and beyond. Our clients have responded enthusiastically to our offering," stated Ed Wise, CEO and Chairman of CDM.

Cline Davis & Mann (http://www.clinedavis.com) is a leading global healthcare communications company. Cline Davis & Mann provides a full range of services, including advertising, managed market strategy, digital and relationship marketing, and consulting. Cline Davis & Mann was named Agency of the Year in 2008 by Med Ad News.

Omnicom Group Inc. (NYSE: OMC) (http://www.omnicomgroup.com) is a leading global marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 100 countries.

For more information please visit: http://www.clinedavis.com and http://www.platformadvisors.com.


'/>"/>
SOURCE Cline Davis & Mann
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Consecos Financial Flexibility and Potentially Disadvantage Other Shareholders
2. Bypass not to blame for heart patients mental decline
3. Long-term cognitive decline in bypass patients not due to surgery
4. New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate
5. Celebrex, Naproxen Wont Prevent Mental Decline
6. Dual treatment of incontinence and dementia associated with functional decline
7. Number of HIV-Positive State and Federal Inmates Continues to Decline
8. Number of U.S. General Surgeons in Decline
9. Teen Pregnancy Rate Declines Five Percent Between 2002 and 2004
10. Study shows decline in work disability due to rheumatoid arthritis
11. Lung Capacity Declines Faster With Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, LLC ... steel (PLS) columns combine the strength of traditional stainless steel with the chemical ... samples while operating at ultra-high pressures of 20,000 psi. The higher operating pressures ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016  Rich Pharmaceuticals, ... today announced a 1-for-100 reverse split of its issued ... opening of trading on Thursday, February 11, 2016. The ... under new CUSIP number 76303T308 and temporary ticker symbol ... commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology: